Tarsus Pharmaceuticals Stock In The News
| TARS Stock | USD 50.22 2.01 3.85% |
Our overall analysis of Tarsus Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Tarsus Pharmaceuticals. The specific impact of Tarsus Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Tarsus Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Tarsus Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Tarsus Pharmaceuticals Backtesting and Tarsus Pharmaceuticals Hype Analysis. For more information on how to buy Tarsus Stock please use our How to Invest in Tarsus Pharmaceuticals guide.
Tarsus |
Tarsus Pharmaceuticals Today Top News and Investor Outlook
Tarsus Pharmaceuticals Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Tarsus and other traded companies coverage with news coverage. We help investors stay connected with Tarsus headlines for the 16th of February 2025 to make an informed investment decision based on correlating the impacts of news items on Tarsus Stock performance. Please note that trading solely based on the Tarsus Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Tarsus Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Tarsus earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Tarsus Pharmaceuticals that are available to investors today. That information is available publicly through Tarsus media outlets and privately through word of mouth or via Tarsus internal channels. However, regardless of the origin, that massive amount of Tarsus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tarsus Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tarsus Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tarsus Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tarsus Pharmaceuticals alpha.
Tarsus Largest EPS Surprises
Earnings surprises can significantly impact Tarsus Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-09 | 2022-09-30 | -0.97 | -0.84 | 0.13 | 13 | ||
2024-05-08 | 2024-03-31 | -1.2 | -1.01 | 0.19 | 15 | ||
2023-03-13 | 2022-12-31 | -0.69 | -0.49 | 0.2 | 28 | ||
2024-11-07 | 2024-09-30 | -0.94 | -0.61 | 0.33 | 35 | ||
2021-11-09 | 2021-09-30 | -0.43 | -0.76 | -0.33 | 76 | ||
2022-08-11 | 2022-06-30 | -0.59 | -0.24 | 0.35 | 59 |
Tarsus Pharmaceuticals Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Tarsus Pharmaceuticals Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
5th of February 2025
Tarsus Pharmaceuticals, Inc. Shares Sold by E. Ohman J or Asset Management AB at thelincolnianonline.com
3rd of February 2025
BofA Adjusts Price Target on Tarsus Pharmaceuticals to 75 From 74 -February 03, 2025 at 10... at news.google.com
30th of January 2025
Exclusive Access Tarsus Pharmas Double-Header at Elite Healthcare Investment Forums - Stoc... at news.google.com
27th of January 2025
Tarsus Pharmaceuticals Trading 9 percent Higher After Analyst Upgrade - MarketBeat at news.google.com
14th of January 2025
Down -9.11 percent in 4 Weeks, Heres Why Tarsus Pharmaceuticals Looks Ripe for a Turnaroun... at finance.yahoo.com
13th of January 2025
Tarsus Pharmaceuticals Inc Announces Strategic Plans for 2025 at gurufocus.com
8th of January 2025
Strength Seen in Novavax Can Its 10.9 percent Jump Turn into More Strength at zacks.com
22nd of November 2024
Mutual of America Capital Management LLC Invests 4.29 Million in Tarsus Pharmaceuticals, I... at news.google.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tarsus Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tarsus Pharmaceuticals' short interest history, or implied volatility extrapolated from Tarsus Pharmaceuticals options trading.
Additional Tools for Tarsus Stock Analysis
When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.